logo
logo
Sign in

Biobanks Market Professional Survey And Ongoing Development Trends By 2028

avatar
Swapnil GVR
Biobanks Market Professional Survey And Ongoing Development Trends By 2028

The global biobanks market size was estimated at USD 65.9 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.2% from 2021 to 2028. High investments for R&D of advanced therapies such as regenerative medicine, personalized medicine, and cancer genomic studies are driving the space.

Collaborations between private and public institutions in biobanking have played a crucial role in market progression. Digitalization, precision medicine, and virtualization are rapidly changing the biobanking industry by the development of novel methods and concepts of synergies initiated by public and private organizations. Companies across all fields are partnering with biobanks which accelerates the market revenue.

For Right Perspective & Competitive Insights, Request a Sample @:

https://www.grandviewresearch.com/industry-analysis/biobanks-industry/request/rs1

An exponential increase in the number of global cases has rendered the significance of biobanks in containing the spread of the virus. High-quality COVID-19 specimens are required and helpful for both research and diagnostic purposes, and biobanks are considered as vital repositories for these samples. Thus, biobanks are gaining ground to support clinical research and drug discovery processes to combat this global disaster.

Key Player Mentioned:

  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • QIAGEN
  • Hamilton Company
  • Avantor
  • Tecan Trading AG.
  • Danaher Corporation
  • Becton, Dickinson and Company (BD)
  • BioCision

Product Segment Analysis:

  • Virtual Biobanks
  • Physical/Real Biobanks

Application Segment Analysis:

  • Therapeutics
  • Drug Discovery & Clinical Research
  • Clinical Diagnostics
  • Other Applications

 

Regional Segment Analysis: North America, Europe, Asia Pacific, Latin America, and Mideast and Africa.

Access Press Release @ https://www.grandviewresearch.com/press-release/global-biobanks-industry

The biobanking equipment segment dominated the market for biobanks and accounted for the largest revenue share of 78.0% in 2020, owing to a rapid increase in the number of new biobanks and the high cost of initial equipment installation. A wide range of equipment is offered to cater to different biobanking processes such as sample preparation, collection, processing, storage, and shipment. The equipment includes cell separators, freezers, thawing equipment, barcode readers, and alarm and monitoring systems.

The biobanking and repository services segment dominated the market for biobanks and accounted for the largest revenue share of 36.0% in 2020. This is owing to the higher market penetration of these services and the increased need for the preservation of biosamples for developing precision medicine and disease-specific research. Expansion of biobanking services from academic research to include clinical enterprises and government initiatives, as well as highly networked and open-ended ventures, has fomented the segment.

The physical/real biobanks segment dominated the market for biobanks and accounted for the largest revenue share of 82.0% in 2020. These biobanks have a well-established network, thereby hold a high revenue share. Rapid progress in the fields of bioinformatics analysis and precision medicine can be attributed to this change in the operating strategy of the biobanks. A large collection of tissue samples from pathological labs, clinical trials, and research projects over the years contributes to the largest share of tissue banks in 2020.

COVID-19 Impact:

The outbreak of the COVID-19 pandemic has significantly increased the demand for antiviral medicines globally. The treatment of novel coronavirus has increased the demand for broad-spectrum Glucose to manage the disease. Remdesivir, favipiravir, oseltamivir, and other combination medicines are highly prescribed for the treatment of COVID-19. Moreover, governments are increasing funding to pharmaceutical companies to develop novel therapeutics against COVID-19. For instance, in June 2021, the U.S. government has announced an investment of more than USD 3 billion to fasten the discovery, development, and manufacturing of antiviral medicines for COVID-19 treatment. The rising incidence of disease coupled with increasing R&D will increase the demand for Glucose in the next 2 to 3 years.

Good Reasons to Buy a Global Biobanks Market Report:

  • Offers detailed market breakdown and data triangulation that will help guide the market trends.
  • The methodology used in the report gives the absolute authentic data that helps advising whether the market has an opportunity in the upcoming years.
  • Provides a detail analysis about the Covid-19 impact on the market and how it will help boost the market in the near future.
  • Give’s a thorough analyst’s viewpoint which guides the client through market collaterals for the better opportunities in the market.
  • Pinpoints the most valued region and how the market can be expanded in the industry to generate more revenue with all the important government guidelines and environmental policies.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

collect
0
avatar
Swapnil GVR
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more